BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2004
View Archived Issues
Boosting endogenous interferon for hepatitis C therapy
Read More
Alutard(R) SQ house dust mite vaccine receives Chinese approval
Read More
Novel GP IIb/IIIa antagonists from Millennium
Read More
New share issue at Medivir; update on Cathepsin and ME-609 projects
Read More
Ganymed and U. of Rotterdam cooperate on identification of new MS pathogens
Read More
Angiotech licenses technologies from U. of British Columbia
Read More
Chewable Zyrtec tablets approved for pediatric patients
Read More
New MAO-B inhibitors and their use claimed by Roche researchers
Read More
Novel Itk inhibitors with potential in immune, inflammatory and allergic disorders
Read More
BMS team prepares and tests HCV NS5A inhibitors
Read More
Lilly claims benzimidazol-based p38 inhibitors for cancer and rheumatoid arthritis
Read More
Novel NPY antagonists covered by Roche patent
Read More
Two series of GlyT inhibitors under study at Sanofi-Synthelabo
Read More
Prous Science announces publication of a comprehensive review on restless legs syndrome
Read More
Good safety and efficacy profile of BIBN-4096BS in acute migraine
Read More
Safety and pharmacokinetics of the ribavirin prodrug viramidine in healthy volunteers
Read More
Increased risk for schizophrenia associated with celiac disease
Read More
Imiquimod reported safe and effective in the treatment of solar keratosis
Read More
New data indicate mechanism of action of Immunitin
Read More
Meta-analysis compares onset of action of antidepressants
Read More
Lexapro as effective as Paxil for generalized anxiety disorder
Read More
Tripep identifies alpha-HGA analogues against HIV
Read More
Roche selects Genmab antibodies as clinical candidates
Read More
Chiron discontinues development of tezacitabine
Read More
Ezetimibe/simvastatin tablets approved in Mexico
Read More
New phase II study investigates Tarceva in poor performance NSCLC patients
Read More
Antisoma updates progress of two anticancer drug candidates
Read More
Biogen Idec highlights 2003 developments
Read More
Axcan Pharma highlights recent developments
Read More
ArQule provides R&D program update
Read More